stock watcher
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Strainsforpains EBYH (OTC: EBYH), Collaborates with Mt. Sinai Hospital in New York City and Johns Hopkins in Baltimore to Merge Advanced AI Data Integrations and Interactions Into Its Proprietary Healthcare APP for Instant Multiple Indications and Critical Ailments Professional Analytics...
https://finance.yahoo.com/news/strainsforpains-ebyh-otc-ebyh-collaborates-133800386.html
Looks like they are making good on their CBD sales growth pattern, AI for pain management hospital programs, and cancer-killing CBG patents. This stock will take off soon.
Strainsforpains EBYH (OTC: EBYH), Collaborates with Mt. Sinai Hospital in New York City and Johns Hopkins in Baltimore to Merge Advanced AI Data Integrations and Interactions Into Its Proprietary Healthcare APP for Instant Multiple Indications and Critical Ailments Professional Analytics...
https://finance.yahoo.com/news/strainsforpains-ebyh-otc-ebyh-collaborates-133800386.html
Looks like they are making good on their CBD sales growth pattern, AI for pain management hospital programs, and cancer-killing CBG patents. This stock will take off soon.
$EBYH
https://www.tradingview.com/chart/?symbol=OTC%3AEBYH
https://finance.yahoo.com/news/strainsforpains-otc-ebyh-formally-announces-133400359.html
Major events planned , Stock structure tight. Revenues up big time.
$EBYH
https://www.tradingview.com/chart/?symbol=OTC%3AEBYH
https://finance.yahoo.com/news/strainsforpains-otc-ebyh-formally-announces-133400359.html
Major events planned , Stock structure tight. Revenues up big time.
$EBYH
https://www.prorealtime.com/en/web/XOTC-EBYH
https://www.globenewswire.com/en/news-release/2024/08/27/2936360/0/en/Strainsforpains-OTC-EBYH-Formally-Announces-Alliance-with-the-1-Million-Strong-Killing-Cancers-Fight-Club-1MSFC-and-the-Inaugural-Live-1MSFC-1-MMA-Fight-for-4th-Quarter-2024-in-Flo.html
$EBYH for the win..Fundamentals and chart look great
https://www.prorealtime.com/en/web/XOTC-EBYH
https://www.globenewswire.com/en/news-release/2024/08/27/2936360/0/en/Strainsforpains-OTC-EBYH-Formally-Announces-Alliance-with-the-1-Million-Strong-Killing-Cancers-Fight-Club-1MSFC-and-the-Inaugural-Live-1MSFC-1-MMA-Fight-for-4th-Quarter-2024-in-Flo.html
$EBYH for the win..Fundamentals and chart,
https://www.prorealtime.com/en/web/XOTC-EBYH
https://www.globenewswire.com/en/news-release/2024/08/27/2936360/0/en/Strainsforpains-OTC-EBYH-Formally-Announces-Alliance-with-the-1-Million-Strong-Killing-Cancers-Fight-Club-1MSFC-and-the-Inaugural-Live-1MSFC-1-MMA-Fight-for-4th-Quarter-2024-in-Flo.html
$EBYH Looking for a continuous breakout in 2024. The float is tight.
$EBYH....https://www.otcmarkets.com/stock/EBYH/overview.....next station One dollar
#EBYH making a move over the last two weeks.
$EBYH is breaking out
https://finance.yahoo.com/quote/EBYH/
$EBYH is breaking out
https://finance.yahoo.com/quote/EBYH/
$EBYH making a move over the last week.
$EBYH breakout...................................
$EBYH breakout...........................................
$EBYH latest news shows JV with cannabis cancer-killing research and patents. Revenues of CBD cream showing a 1000% increase from 2023. Check out https://www.strainsforpains.com/
CEO INTERVIEW
$EBYH... see you at a dollar
https://stockscan.io/stocks/EBYH#google_vignette
https://stockscan.io/stocks/EBYH#google_vignette
get ready for a rocket ride
https://ih.advfn.com/stock-market/USOTC/e-buy-home-pk-EBYH/chart/streaming
$EBYH...starting its rise to a dollar
$EBYH is starting to rock.
https://ih.advfn.com/stock-market/USOTC/e-buy-home-pk-EBYH/chart/streaming
https://ih.advfn.com/stock-market/USOTC/e-buy-home-pk-EBYH/chart/streaming
EBYH is starting to rock.
$EBYH signs strategic partnership
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
HERE ARE POSITIVE POINTS OF COMPANY
Strategic partnership with Cannabis Science for cannabinoid drug commercialization
Access to Harvard Award-winning cancer research and patented CBN products
Recent orders totaling $195,000 in Q4 2023 and early 2024
Projected sales to surpass $500,000 in 2024
Established partnerships with hemp farmers in Virginia and Pennsylvania
Expansion of CBD product line planned for 2024
Potential for NASDAQ uplisting due to revenue and asset expansion
$EBYH news out today
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
HERE ARE POSITIVE POINTS OF COMPANY
Strategic partnership with Cannabis Science for cannabinoid drug commercialization
Access to Harvard Award-winning cancer research and patented CBN products
Recent orders totaling $195,000 in Q4 2023 and early 2024
Projected sales to surpass $500,000 in 2024
Established partnerships with hemp farmers in Virginia and Pennsylvania
Expansion of CBD product line planned for 2024
Potential for NASDAQ uplisting due to revenue and asset expansion
$EBYH news out today
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
HERE ARE POSITIVE POINTS OF COMPANY
Strategic partnership with Cannabis Science for cannabinoid drug commercialization
Access to Harvard Award-winning cancer research and patented CBN products
Recent orders totaling $195,000 in Q4 2023 and early 2024
Projected sales to surpass $500,000 in 2024
Established partnerships with hemp farmers in Virginia and Pennsylvania
Expansion of CBD product line planned for 2024
Potential for NASDAQ uplisting due to revenue and asset expansion
$EBYH announces strategic partnership
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
What is the new partnership announced by Strainsforpains (EBYH)?
Strainsforpains (EBYH) has signed a strategic product commercialization agreement with Cannabis Science for international retail and wholesale cannabinoid drug distribution.
What are the projected sales for Strainsforpains (EBYH) in 2024?
Strainsforpains (EBYH) projects to surpass $500,000 in sales for 2024, based on recent orders and expanding partnerships.
What key products are included in the Strainsforpains (EBYH) and Cannabis Science partnership?
The partnership includes Cannabis Science's Harvard Award-winning cancer research and CBN patent for sleep and neurological disorders, as well as Strainsforpains' existing CBD product line.
How much in orders has Strainsforpains (EBYH) received recently?
Strainsforpains (EBYH) has received orders totaling $195,000, with $65,000 in Q4 2023 and $130,000 in early 2024.
$EBYH news out today
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
What is the new partnership announced by Strainsforpains (EBYH)?
Strainsforpains (EBYH) has signed a strategic product commercialization agreement with Cannabis Science for international retail and wholesale cannabinoid drug distribution.
What are the projected sales for Strainsforpains (EBYH) in 2024?
Strainsforpains (EBYH) projects to surpass $500,000 in sales for 2024, based on recent orders and expanding partnerships.
What key products are included in the Strainsforpains (EBYH) and Cannabis Science partnership?
The partnership includes Cannabis Science's Harvard Award-winning cancer research and CBN patent for sleep and neurological disorders, as well as Strainsforpains' existing CBD product line.
How much in orders has Strainsforpains (EBYH) received recently?
Strainsforpains (EBYH) has received orders totaling $195,000, with $65,000 in Q4 2023 and $130,000 in early 2024.
$EBYH news out
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
What is the new partnership announced by Strainsforpains (EBYH)?
Strainsforpains (EBYH) has signed a strategic product commercialization agreement with Cannabis Science for international retail and wholesale cannabinoid drug distribution.
What are the projected sales for Strainsforpains (EBYH) in 2024?
Strainsforpains (EBYH) projects to surpass $500,000 in sales for 2024, based on recent orders and expanding partnerships.
What key products are included in the Strainsforpains (EBYH) and Cannabis Science partnership?
The partnership includes Cannabis Science's Harvard Award-winning cancer research and CBN patent for sleep and neurological disorders, as well as Strainsforpains' existing CBD product line.
How much in orders has Strainsforpains (EBYH) received recently?
Strainsforpains (EBYH) has received orders totaling $195,000, with $65,000 in Q4 2023 and $130,000 in early 2024.
$EBYH-This morning's news .
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
CSi-CBN Patent:
“Composition for Treatment of Neurobehavioral Disorders” Protections and Product Release, Sleep, PTSD, Neurological Conditions. US Patent number US10413578. CBN Sleep Products for Sleep Deprivation, PTSD, OCD, ADHD and more. The Sleep deprivation and PTSD markets combined are well over $500 Billion Worldwide with a shortage of cost effect treatments and therapies. Leaving the opportunity to fulfill this demand a major windfall.
patents.google.com/patent/US10413578B2/en
$EBYH Strainsforpains reporting 136k revenues first quarter! last 4 months it has booked 200k. They will be dramatically increasing in sales when they go national. CBD relief for pain.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/financial-report/403167/content
$EBYH Strainsforpains reporting 136k revenues first quarter! last 4 months it has booked 200k. They will be dramatically increasing in sales when they go national. CBD relief for pain.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/financial-report/403167/content
$EBYH
Strainsforpains reported 136k revenues first quarter! last 4 months it has booked 200k. They will be dramatically increasing in sales when they go national, then global. The float is still small. No dilution.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/financial-report/403167/content
$EBYH
Strainsforpains reported 136k revenues first quarter! last 4 months it has booked 200k. They will be dramatically increasing in sales when they go national, then global. The float is still small. No dilution.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/financial-report/403167/content
$EBYH
Strainsforpains reported 136k revenues first quarter! last 4 months it has booked 200k. They will be dramatically increasing in sales when they go national, then global. Float is still small. No dilution.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/financial-report/403167/content
$EBYH Look at the website and news https://www.strainsforpains.com/
https://finance.yahoo.com/quote/EBYH Quarterly financials coming out by tomorrow.
Tight float, substantial revenue increase, new CBD product with advanced scientific anti-oxidant additives Phd/MD on board. 2024 should see huge price move.
$EBYH is very undervalued and the float and outstanding and very conservative. This stock is the best long term play in the cannabis data and technology part of the industry. With the high probability that Schedule 1 goes to schedule 3 in 2024, Strainsforpains’ services and products will be in great demand.
Here is promo video, CEO audio, as well as video interview.
Here is the interview with the company CEO
$EBYH
Here are three news releases on company's progress
https://finance.yahoo.com/news/strainsforpains-inc-investors-strainsforpains-inc-130000775.html
https://finance.yahoo.com/news/strainsforpains-ceo-simon-shainberg-discusses-120000687.html
https://finance.yahoo.com/news/strainsforpains-inc-discusses-inspiration-app-140000889.html
Here is a YouTube video of a promo for company